Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinlarebant in adolescent Stargardt disease
NCT05266014Phase 2Completed
- Sponsor
- RBP4
- Start
- Mar 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tinlarebant in Stargardt disease (STGD), sponsored by RBP4. Started Mar 2021; status: completed.
02
Drugs
tinlarebant
03
Conditions
Stargardt disease (STGD)
Beyond the preview
Go deeper on NCT05266014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266014.